Get started

Rally Foundation

Homepage URL: rallyfoundation.org
Alternate names: Rally Foundation, Inc, Rally, RALLY FOUNDATION INC, Rally Foundation, Inc., Rally Foundation Inc., Rally Foundation for Childhood Cancer Research
Description: nonprofit organization in Sandy Springs, United States
Country: US
ROR: 01mkym489
Wikidata ID: entity/Q30288740
Crossref ID: 100003287
DOI: 10.13039/100003287
OpenAlex ID: F4320307428
The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers
2017 · Burak H. Alver, Kimberly H. Kim, et al. · Nature Communications · 442
PDF
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
2021 · Gregory K. Friedman, James M. Johnston, et al. · New England Journal of Medicine · 347
PDF
N-methyladenine DNA Modification in Glioblastoma
2018 · Qi Xie, Tao P. Wu, et al. · Cell · 331
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
2019 · Malgorzata Krajewska, Ruben Dries, et al. · Nature Communications · 295
PDF
The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia
2017 · Marta Sanchez-Martin, Adolfo Ferrando · Blood · 266
PDF
Glioma stem cells and their roles within the hypoxic tumor microenvironment
2020 · Nathaniel H. Boyd, Anh Nhat Tran, et al. · Theranostics · 224
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis
2016 · Vijay Ramaswamy, Thomas Hielscher, et al. · Journal of Clinical Oncology · 209
Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG
2019 · Jamie N. Anastas, Barry M. Zee, et al. · Cancer Cell · 197
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia
2016 · Koichi Oshima, Hossein Khiabanian, et al. · Proceedings of the National Academy of Sciences · 196
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer
2017 · Michael R. Burgess, Eugene Hwang, et al. · Cell · 184
PDF
EP300 Selectively Controls the Enhancer Landscape of MYCN -Amplified Neuroblastoma
2021 · Adam D. Durbin, Tingjian Wang, et al. · Cancer Discovery · 182
PDF
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
2018 · Bill H. Diplas, Xujun He, et al. · Nature Communications · 176
PDF
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
2025 · Adam J. Grippin, Christiano Marconi, et al. · Nature · 172
Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
2011 · Lễ B. Nguyễn, Sharon J. Diskin, et al. · PLoS Genetics · 169
PDF
RNA aggregates harness the danger response for potent cancer immunotherapy
2024 · Hector R. Mendez-Gomez, Anna DeVries, et al. · Cell · 168
PDF
A predictive microfluidic model of human glioblastoma to assess trafficking of blood–brain barrier-penetrant nanoparticles
2022 · Joelle P. Straehla, Cynthia Hajal, et al. · Proceedings of the National Academy of Sciences · 168
Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
2018 · Presha Rajbhandari, Gonzalo Lopez, et al. · Cancer Discovery · 168
PDF
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia
2016 · Sarah K. Tasian, David T. Teachey, et al. · Blood · 165
PDF
A first-generation pediatric cancer dependency map
2021 · Neekesh V. Dharia, Guillaume Kugener, et al. · Nature Genetics · 156
H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2
2020 · Siddhant U. Jain, Andrew Q. Rashoff, et al. · Molecular Cell · 150
PDF
Cilia-Associated Oxysterols Activate Smoothened
2018 · David R. Raleigh, Navdar Sever, et al. · Molecular Cell · 136
PDF
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination
2016 · Jungoh Ham, Carlotta Costa, et al. · Cancer Cell · 135
PDF
YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma
2020 · Krishanthan Vigneswaran, Nathaniel H. Boyd, et al. · Clinical Cancer Research · 134
Oncolytic Virotherapy for the Treatment of Malignant Glioma
2017 · Paul M. Foreman, Gregory K. Friedman, et al. · Neurotherapeutics · 134
PDF
Genetic loss of SH2B3 in acute lymphoblastic leukemia
2013 · Arianne Perez-Garcia, Alberto Ambesi-Impiombato, et al. · Blood · 134
Works count: 600
Citation count: 19,070
H-index: 75
I10-index: 335
2-year mean citedness: 9.49
Awards count: 83
Year
Topic
Type